A study by Indiana University School of Medicine and the Regenstrief Institute reviewed and analyzed the findings of 31 studies with a total of 120,255 participants. Each individual had a fecal immunochemical test, which identifies hidden blood in stool. FIT results were compared to the finding of a subsequent screening colonoscopy and were found to have high detection rates for colorectal cancer.
In this episode of the Cancer Letter Podcast, all three of The Cancer Letter’s reporters come together to talk about the potential impact of President Donald Trump’s tariffs on cancer care.
